Rhonda E. Schnur

4.2k total citations
52 papers, 919 citations indexed

About

Rhonda E. Schnur is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Rhonda E. Schnur has authored 52 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Genetics and 15 papers in Cell Biology. Recurrent topics in Rhonda E. Schnur's work include melanin and skin pigmentation (12 papers), RNA regulation and disease (8 papers) and Genetics and Neurodevelopmental Disorders (6 papers). Rhonda E. Schnur is often cited by papers focused on melanin and skin pigmentation (12 papers), RNA regulation and disease (8 papers) and Genetics and Neurodevelopmental Disorders (6 papers). Rhonda E. Schnur collaborates with scholars based in United States, Canada and Netherlands. Rhonda E. Schnur's co-authors include Elaine H. Zackai, Richard A. Spritz, Warren R. Heymann, Nancy B. Spinner, Donna M. McDonald‐McGinn, Stuart A. Holmes, Richard G. Weleber, Paul J. Honig, Arlene J. Herzberg and Maria A. Musarella and has published in prestigious journals such as Nature Communications, Nature Genetics and The Journal of Immunology.

In The Last Decade

Rhonda E. Schnur

50 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rhonda E. Schnur United States 20 505 333 261 127 105 52 919
A.F. Markham United Kingdom 16 566 1.1× 147 0.4× 194 0.7× 35 0.3× 32 0.3× 35 1.0k
Vincent M. Aita United States 13 803 1.6× 180 0.5× 431 1.7× 16 0.1× 98 0.9× 16 1.3k
Andrew R. Cullinane United States 16 390 0.8× 401 1.2× 205 0.8× 40 0.3× 27 0.3× 20 824
Asem Alkhateeb Jordan 16 308 0.6× 113 0.3× 720 2.8× 301 2.4× 170 1.6× 32 1.2k
Anne R. Murray United States 15 483 1.0× 103 0.3× 84 0.3× 17 0.1× 36 0.3× 23 781
Ugur Yavuzer Türkiye 21 723 1.4× 119 0.4× 359 1.4× 175 1.4× 60 0.6× 27 1.2k
Nobuhiro Ibaraki Japan 15 512 1.0× 68 0.2× 111 0.4× 20 0.2× 22 0.2× 32 1.1k
Alyne Ricker United States 11 544 1.1× 602 1.8× 75 0.3× 38 0.3× 21 0.2× 14 1.3k
Jens Schuster Sweden 19 712 1.4× 247 0.7× 134 0.5× 17 0.1× 12 0.1× 49 1.1k
Essam Al‐Sabban Saudi Arabia 10 911 1.8× 107 0.3× 95 0.4× 239 1.9× 5 0.0× 30 1.5k

Countries citing papers authored by Rhonda E. Schnur

Since Specialization
Citations

This map shows the geographic impact of Rhonda E. Schnur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhonda E. Schnur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhonda E. Schnur more than expected).

Fields of papers citing papers by Rhonda E. Schnur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhonda E. Schnur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhonda E. Schnur. The network helps show where Rhonda E. Schnur may publish in the future.

Co-authorship network of co-authors of Rhonda E. Schnur

This figure shows the co-authorship network connecting the top 25 collaborators of Rhonda E. Schnur. A scholar is included among the top collaborators of Rhonda E. Schnur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhonda E. Schnur. Rhonda E. Schnur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schnur, Rhonda E., Louisa Kalsner, Dana Grebeňová, et al.. (2024). New kinase‐deficient PAK2 variants associated with Knobloch syndrome type 2. Clinical Genetics. 106(4). 518–524. 4 indexed citations
2.
Dang, An, Irene J. Chang, Lynne A. Wolfe, et al.. (2023). Elevated oxysterol and N‐palmitoyl‐O‐phosphocholineserine levels in congenital disorders of glycosylation. Journal of Inherited Metabolic Disease. 46(2). 326–334. 4 indexed citations
3.
Cui, Hong, Joseph M. Devaney, Xinyue Liu, et al.. (2021). Interference of nuclear mitochondrial DNA segments in mitochondrial DNA testing resembles biparental transmission of mitochondrial DNA in humans. Genetics in Medicine. 23(8). 1514–1521. 9 indexed citations
4.
Valencia, Ignacio, Joseph J. Melvin, Agustín Legido, et al.. (2020). Boricua Founder Variant in FRRS1L Causes Epileptic Encephalopathy With Hyperkinetic Movements. Journal of Child Neurology. 36(2). 93–98. 2 indexed citations
5.
Ferrer, Alejandro, Ingrid M.B.H. van de Laar, Kazuhiko Namekata, et al.. (2019). Variants in DOCK3 cause developmental delay and hypotonia. European Journal of Human Genetics. 27(8). 1225–1234. 13 indexed citations
6.
Schnur, Rhonda E., et al.. (2017). Melanoma and basal cell carcinoma in the hereditary leiomyomatosis and renal cell cancer syndrome. An expansion of the oncologic spectrum.. Journal of Dermatological Case Reports. 10(3). 53–55. 2 indexed citations
7.
Tanaka, Akemi, Megan T. Cho, Rebecca Willaert, et al.. (2017). De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism. Molecular Case Studies. 3(6). a002097–a002097. 23 indexed citations
8.
Schnur, Rhonda E., et al.. (2014). Clinical and genetic complexity of Mitchell–Riley/Martinez–Frias syndrome. Journal of Perinatology. 34(12). 948–950. 7 indexed citations
9.
Epstein, Michael P., Rhonda E. Schnur, Fernando Scaglia, et al.. (2005). Epimerase-Deficiency Galactosemia Is Not a Binary Condition. The American Journal of Human Genetics. 78(1). 89–102. 58 indexed citations
10.
Schnur, Rhonda E.. (2004). Genodermatoses 2003-2004. Current Opinion in Pediatrics. 16(6). 678–688. 5 indexed citations
11.
Touloukian, Christopher E., Wolfgang W. Leitner, Rhonda E. Schnur, et al.. (2003). Normal Tissue Depresses While Tumor Tissue Enhances Human T Cell Responses In Vivo to a Novel Self/Tumor Melanoma Antigen, OA1. The Journal of Immunology. 170(3). 1579–1585. 18 indexed citations
12.
Das, Soma, Christa M. Lese, Minsun Song, et al.. (2000). Partial Paternal Uniparental Disomy of Chromosome 6 in an Infant with Neonatal Diabetes, Macroglossia, and Craniofacial Abnormalities. The American Journal of Human Genetics. 67(6). 1586–1591. 27 indexed citations
13.
Spritz, Richard A., Jangsuk Oh, Kazuyoshi Fukai, et al.. (1997). Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1). Human Mutation. 10(2). 171–174. 45 indexed citations
14.
Rebbeck, Timothy R., et al.. (1997). Utility of linked markers in genetic counseling: Estimation of carrier risks in X-linked ocular albinism. American Journal of Medical Genetics. 70(1). 58–66. 1 indexed citations
15.
Schnur, Rhonda E., et al.. (1996). Type I Oculocutaneous Albinism Associated with a Full-Length Deletion of the Tyrosinase Gene. Journal of Investigative Dermatology. 106(5). 1137–1140. 19 indexed citations
17.
Zackai, Elaine H., et al.. (1995). Reevaluation of a kindred with congenital absence of dermal ridges, syndactyly, and facial milia. Journal of the American Academy of Dermatology. 32(2). 315–318. 7 indexed citations
18.
Schnur, Rhonda E., Kimberly Grace, & Arlene J. Herzberg. (1994). Buschke‐Ollendorff Syndrome, Otosclerosis, and Congenital Spinal Stenosis. Pediatric Dermatology. 11(1). 31–34. 11 indexed citations
19.
Schnur, Rhonda E., et al.. (1993). Deletion Mapping and a Highly Reduced Radiation Hybrid in the Xp22.3-p22.2 Region. Genomics. 15(3). 500–506. 5 indexed citations
20.
Schnur, Rhonda E., et al.. (1991). Linkage analysis in X-linked ocular albinism. Genomics. 9(4). 605–613. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026